×

Growth Reports

Growth Reports
Report Name

NGS Informatics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Products and Services (NGS Informatics Services, Data Analysis and Management Tool, Primary and Secondary Data Analysis Tools), By Application (Drug Discovery, Genetic Screening, Precision Medicine, Others), By End-User (Hospitals, Clinics, Research Institutes, Others), Countries and Companies Report

NGS Informatics is projected to register a 14.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024907  |   No. of Pages: 205

Next Generation Immunology Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Small Molecules, Antibodies, Cell Based Therapies, Others), By Therapeutic Area (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Others), Countries and Companies Report

Next Generation Immunology Drugs is projected to register a 6.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024906  |   No. of Pages: 205

Next Generation Antibody Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Therapeutic Area (Oncology, Autoimmune/Inflammatory), By Technology (Antibody-Drug Conjugates (ADCs), Bispecific Antibodies (BsAbs), Fc-Engineered Antibodies, Antibody Fragments and Antibody-Like Proteins (AF & ALPs), Biosimilar Antibody Products), Countries and Companies Report

Next Generation Antibody Therapeutics is projected to register a 12.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024905  |   No. of Pages: 205

Newborn Screening Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Consumables, Instruments, Accessories, Devices, Pulse oximeters), By Test (Dry blood spot tests, Hearing screening tests, CCHD screening tests), By Technology (Immune assays & enzymatic assays, Tandem mass spectrometry, Molecular assays, Hearing screening technologies, Pulse oximetry, Others), By End-User (Clinical Laboratories, Hospitals), Countries and Companies Report

Newborn Screening is projected to register a 8.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024904  |   No. of Pages: 205

Neurovascular Access Catheters Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Single Lumen Catheters, Double Lumen Catheters, Multiple Lumen Catheters), By Material (Liquid Crystal Polymer, Fluorinated Ethylene Propylene, Others), Countries and Companies Report

Neurovascular Access Catheters is projected to register a 6.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024903  |   No. of Pages: 205

Neurorehabilitation Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Neuro-Robotic Devices, Non-Invasive Stimulators, Brain-Computer Interfaces), By Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, Others), By End-User (Rehabilitation Centers, Hospitals, Clinics), Countries and Companies Report

Neurorehabilitation is projected to register a 12.6% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024902  |   No. of Pages: 205

Neuroprotective Agents Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Anesthetics, Antagonists, Antidepressants, Cytokines, Others), By Application (Alzheimer's disease, Dementia, Epilepsy, Multiple sclerosis, Others), By Route of Administration (Oral, Topical, Epidural, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), Countries and Companies Report

Neuroprotective Agents is projected to register a 7.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024901  |   No. of Pages: 205

Neuropathic Pain Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Indication (Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-induced Peripheral Neuropathy, Others), By Drug Class (Tricyclic Antidepressants, Opioids, Capsaicin Cream, Steroids, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), Countries and Companies Report

Neuropathic Pain is projected to register a 5.9% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024900  |   No. of Pages: 205

Neurology Monitoring Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Magnetic Resonance Imaging (MRI) Devices, Electroencephalography devices, Cerebral Oximeters, Intracranial Pressure Monitors, Others), By Disease (Traumatic Brain Injury (TBI), Stroke, Sleep Disorders, Parkinson's Disease, Epilepsy, Others), Countries and Companies Report

Neurology Monitoring is projected to register a 6.1% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024899  |   No. of Pages: 205

Neurological Disorder Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Countries and Companies Report

Neurological Disorder Drugs is projected to register a 5.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024898  |   No. of Pages: 205

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us